Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer (clinicaltrials.gov) - Jun 17, 2026 - P1 | N=9 | Completed | Sponsor: Praful Ravi, MB BCHir, MRCP | Active, not recruiting ➔ Completed
Trial completion • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Adenocarcinoma • Prostate Cancer • Solid Tumor
|